BAY CAPITAL PLC (LSE: BAY) — Research note

Executive summary

Bay Capital is a Jersey-domiciled cash shell listed on the LSE Main Market in September 2021 with the stated purpose of finding an inaugural acquisition; it has no operating business, no revenue and roughly £4.3m of cash at the December 2025 year-end 2026-04-30 FY 2025. Across the five years of filings the trajectory has been simple: cash has steadily been consumed by listing costs, modest director fees and adviser retainers (~£0.3–1.4m of net annual cash outflow), and no transaction has been completed. The single most important point for valuation today is that the company's intrinsic value is essentially its net cash, which at 31 Dec 2025 equates to ~6.1p/share against a quoted market cap implying ~6.75p/share — i.e. the shares already trade close to liquidation value with optionality, not fundamentals, doing the marginal work.

Fair value estimate

Methodology: NAV / net-cash backing with optionality adjustment. The company has no operating earnings, no revenue, no comparable peer multiples that translate cleanly, and no completed transaction. The only defensible anchor is cash less near-term liabilities, plus a thin warrant/optionality adjustment for the chance of a value-accretive deal.

Inputs (at 31 Dec 2025) 2026-04-30 FY 2025:

Cash: £4,338,374
Trade & other receivables: £12,045
Trade & other payables: £(85,459)
Net tangible assets: £4,264,960
Shares in issue: 70,000,000
Net tangible asset value per share: 6.09p

The post-balance sheet cash burn (cash £4.24m at 14 April 2026) implies cash NAV continues to drift down at ~£0.3m/year, i.e. ~0.45p/share/year of value destruction in the absence of a deal.

Range:

Low: 5.0p/share (£3.5m) — assumes another 18–24 months of fruitless deal search consuming cash, with no acquisition.
High: 7.0p/share (£4.9m) — net cash plus a modest premium for warrant/deal optionality, capped because warrants struck at 10p only become exercisable after a £10m+ deal completes and would dilute outside shareholders.
Central: ~6.0p/share (£4.2m) — broadly net cash today.

Implied market cap range: £3.5m – £4.9m (mid £4.2m). Current market cap (given): £4.7m → implied 6.75p/share. Upside/downside to midpoint: ~ −11%; to high end: ~ +4%; to low end: ~ −26%.

Bottom line: shares already trade roughly at — or modestly above — defensible net-cash value, despite no deal in sight.

Sector context

Classification confirmed: Financials / Financial Services (acquisition vehicle / cash shell). The quality/growth/leverage profile is below typical peers: no revenue, no operating earnings, no portfolio assets — pure pre-deal cash shell. Closest listed peers are other Main Market/AIM cash shells controlled by the same investor cohort, all chaired by David Williams: Acceler8 Ventures Plc (LSE: AC8) and Red Capital Plc (LSE: REDC); analogous templates include Marwyn-affiliated vehicles and historically Breedon Group in its pre-deal cash-shell phase. The Breedon precedent is the bull-case template the board explicitly markets to.

Investment thesis (3 bullets)

Track record of the principals. David Williams and the late-stage adviser Tony Morris come from a school (Marwyn / Breedon) where listed cash shells have been turned into multi-bagger operating businesses — Breedon was built from a £13m shell into a £1.5bn business 2026-04-30 FY 2025, "Company Directors". If a deal of similar character is executed, the warrants (29.25m at 10p, now 14.5m post-Tom departure) become real optionality.
Broadened mandate increases the chance of getting a deal done. In November 2025 the board broadened the investment strategy beyond industrials/construction into higher-growth sectors, and explicitly says a "meaningful pipeline of executable opportunities" is now being evaluated with the aim of advancing it during H1 2026 2026-04-30 FY 2025, Chairman's Statement. This shift, combined with the new chair, materially raises the conditional probability of an inaugural transaction landing.
Net-cash backing limits downside. With ~6.1p of net tangible cash per share and ~£0.3m annual burn, the principal downside risk is time-value erosion rather than capital impairment in the near term, giving the shares a more defensible floor than typical micro-caps 2026-04-30 FY 2025, Statement of Financial Position.

Key risks (3 bullets)

Five-year failure to deploy. The shell has been listed since September 2021 and has run >4.5 years without completing a transaction; the prior chairman has retired and the original industrials thesis has been quietly abandoned, which is itself an admission that the initial mandate failed 2026-04-30 FY 2025; src: 2025-04-30 FY 2024. The probability of further drift or eventual wind-up rather than a deal cannot be dismissed.
Governance and dilution risk on any deal. Founders hold 14.5m warrants exercisable at 10p once a £10m+ transaction completes, and the Subco scheme entitles participants to up to 15% of created shareholder value above a 10% compound hurdle 2026-04-30 FY 2025, "Warrants" / "Subco Incentive Scheme". A deal completed at modest valuation could be heavily diluted in favour of insiders; the related-party Tessera adviser is paid ~£120k/year regardless 2026-04-30 FY 2025, Note 19.
Risk of overpaying / poor deal selection. With only ~£4.3m of cash, any meaningful deal will require either a heavy share issue at depressed prices or material leverage; either path could destroy shareholder value if the target is mispriced. The 2023 accounts already show ~£1m of acquisition-related costs charged against P&L for a deal that did not complete 2024-04-24 FY 2023, Note 6, evidence that diligence spend can be sunk without payoff.

Operating leverage

The company is currently pre-revenue with effectively 100% of its cost base fixed (director fees £50k, Tessera retainer ~£120k, auditor £28k, legal/professional ~£196k, totaling ~£0.34m of admin expense in 2025) 2026-04-30 FY 2025, Notes 4, 6, 19. There is no operating leverage to model because there is no revenue. The "leverage" available to shareholders is purely transaction leverage: a successful deal that re-rates the equity above 10p triggers warrants and incentive scheme dilution; below the 10p / 10% compound hurdle, the insider share is muted. Until a deal is announced the operating leverage discussion is academic — the chassis has no engine.

Value-trap signals

Repeated guidance slippage on deal completion — successive chairman statements from 2022, 2023, 2024 and 2025 all promised the inaugural transaction "in due course"; none has materialised.
Strategy pivot late in the life of the shell (Nov 2025) — broadening from industrials to "higher growth sectors" suggests the original thesis didn't yield executable targets.
Departure of the founding industrials chairman (Peter Tom) and the buy-back of his Subco B-shares for £1 2026-04-30 FY 2025, Subco Incentive Scheme note removes the very pedigree that underpinned the IPO marketing.
Material related-party adviser fees to Tessera (~£120k/yr) flowing to a firm where the newly appointed NED holds 50% 2026-04-30 FY 2025, Note 19.
Ongoing cash burn vs. zero revenue with no realistic timeline to break-even absent a transaction.

Earnings vs. expectations

There is no operating earnings track record to compare to consensus — the company is pre-revenue and pre-acquisition. The only management commitment that can be tested is the recurring promise of an "inaugural transaction"; on that, every chairman's statement from FY21 onwards has signalled progress while failing to deliver a completed deal, a de facto repeated miss versus stated strategic intent. Reported losses (FY22 £0.25m, FY23 £1.31m, FY24 £0.55m, FY25 £0.32m) reflect the cost of being listed plus episodic deal-diligence write-offs and are not a meaningful EPS comparison.

Conviction

Conviction: 4 — high (on the fair-value call that the shares trade close to net cash).

Anchors: (i) the balance sheet is simple and audited — cash is real and liabilities are minimal; (ii) the methodology (NAV) is the only one a cash shell admits, and the cash figure is corroborated by post-balance sheet disclosure in April 2026; (iii) all valuation roads converge to "roughly net cash plus a thin optionality stub."

Caveats: (i) the optionality value is hard to size — a transformative Breedon-style deal would render the NAV anchor irrelevant; (ii) the structure of warrants and the Subco scheme makes equity dilution on any deal hard to forecast precisely.

Driver scoring

AI-beneficiary (15): No AI exposure of any kind. A cash shell hunting for industrials/construction (and now "higher growth") targets is not a recipient of AI capex.
Operating leverage (10): No revenue and therefore no operating leverage. Cost base is fixed but small; there is no engine to leverage.
Earnings surprise trend (50): Not enough data — no recurring earnings to beat or miss. Default 50.
Cyclicality (40): The shell itself is uncorrelated to cycles, but its only realistic targets sit in cyclical sectors (industrials, construction, "higher growth" likely meaning tech/services). Calibrated as moderate.
Moat (5): No business, no moat.
Leverage (5): Net cash, no debt — fortress balance sheet for what it is.
Earnings quality (60): Reported losses are clean and simple; no operating earnings to opine on. Some related-party flow to Tessera and insider-rich incentive scheme reduce the score modestly.
Management quality (60): Strong CVs (Breedon, Aggregate Industries, Marwyn) but the practical track record at this vehicle is 4½ years without a deal — pedigree without delivery.
Growth momentum (15): No revenue, no growth; the only momentum on display is cash erosion.

Overall score

Overall score: 90 / 1000.

Rationale: Bay Capital fails almost every criterion the investor profile screens for — no AI receiver exposure, no operating leverage, no quantifiable upside drop-through, no demonstrable execution. Its only redeeming features (net cash backing and a clean balance sheet) are necessary but not remotely sufficient. The shares price-in some deal optionality that, given the 4½-year history, is unlikely to be cheap when bought here.